These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 12580565)
41. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma. Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766 [TBL] [Abstract][Full Text] [Related]
42. Genetic basis of cancer of the kidney: disease-specific approaches to therapy. Linehan WM; Vasselli J; Srinivasan R; Walther MM; Merino M; Choyke P; Vocke C; Schmidt L; Isaacs JS; Glenn G; Toro J; Zbar B; Bottaro D; Neckers L Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6282S-9S. PubMed ID: 15448018 [TBL] [Abstract][Full Text] [Related]
43. [Hereditary renal tumors: More common than expected?]. Agaimy A; Hartmann A Pathologe; 2016 Mar; 37(2):134-43. PubMed ID: 26979427 [TBL] [Abstract][Full Text] [Related]
44. Risk factors, genetic predisposition and mutations in the VHL gene in sporadic renal cell carcinoma: The Netherlands Cohort Study. Van Dijk BA; Schouten LJ; Hulsbergen-van de Kaa CA; van Houwelingen KP; Schalken JA; Kiemeney LA; Geurts van Kessel AH; Bausch-Goldbohm RA; van den Brandt PA IARC Sci Publ; 2002; 156():509-10. PubMed ID: 12484247 [No Abstract] [Full Text] [Related]
46. Loss of HNF1alpha function in human renal cell carcinoma: frequent mutations in the VHL gene but not the HNF1alpha gene. Lemm I; Lingott A; Pogge v Strandmann E; Zoidl C; Bulman MP; Hattersley AT; Schulz WA; Ebert T; Ryffel GU Mol Carcinog; 1999 Apr; 24(4):305-14. PubMed ID: 10326868 [TBL] [Abstract][Full Text] [Related]
47. Chromosome 3 translocations and the risk to develop renal cell cancer: a Dutch intergroup study. Van Erp F; Van Ravenswaaij C; Bodmer D; Eleveld M; Hoogerbrugge N; Mulders P; Geurts van Kessel A Genet Couns; 2003; 14(2):149-54. PubMed ID: 12872808 [TBL] [Abstract][Full Text] [Related]
48. Role of VHL gene mutation in human cancer. Kim WY; Kaelin WG J Clin Oncol; 2004 Dec; 22(24):4991-5004. PubMed ID: 15611513 [TBL] [Abstract][Full Text] [Related]
49. Radiological evaluation, management, and surveillance of renal masses in Von Hippel-Lindau disease. Meister M; Choyke P; Anderson C; Patel U Clin Radiol; 2009 Jun; 64(6):589-600. PubMed ID: 19414081 [TBL] [Abstract][Full Text] [Related]
50. Understanding familial and non-familial renal cell cancer. Bodmer D; van den Hurk W; van Groningen JJ; Eleveld MJ; Martens GJ; Weterman MA; van Kessel AG Hum Mol Genet; 2002 Oct; 11(20):2489-98. PubMed ID: 12351585 [TBL] [Abstract][Full Text] [Related]
51. Von Hippel-Lindau syndrome: hereditary cancer arising from inherited mutations of the VHL tumor suppressor gene. Humphrey JS; Klausner RD; Linehan WM Cancer Treat Res; 1996; 88():13-39. PubMed ID: 9239471 [No Abstract] [Full Text] [Related]
52. VHL expression in renal cell carcinoma sensitizes to bortezomib (PS-341) through an NF-kappaB-dependent mechanism. An J; Fisher M; Rettig MB Oncogene; 2005 Feb; 24(9):1563-70. PubMed ID: 15608669 [TBL] [Abstract][Full Text] [Related]
53. Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma: relationship to clinicopathological parameters. Kondo K; Yao M; Yoshida M; Kishida T; Shuin T; Miura T; Moriyama M; Kobayashi K; Sakai N; Kaneko S; Kawakami S; Baba M; Nakaigawa N; Nagashima Y; Nakatani Y; Hosaka M Genes Chromosomes Cancer; 2002 May; 34(1):58-68. PubMed ID: 11921283 [TBL] [Abstract][Full Text] [Related]
54. Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas. Na X; Wu G; Ryan CK; Schoen SR; di'Santagnese PA; Messing EM J Urol; 2003 Aug; 170(2 Pt 1):588-92. PubMed ID: 12853836 [TBL] [Abstract][Full Text] [Related]
55. Vascular endothelial growth factor overexpression is correlated with von Hippel-Lindau tumor suppressor gene inactivation in patients with sporadic renal cell carcinoma. Igarashi H; Esumi M; Ishida H; Okada K Cancer; 2002 Jul; 95(1):47-53. PubMed ID: 12115316 [TBL] [Abstract][Full Text] [Related]
56. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma. Clifford SC; Astuti D; Hooper L; Maxwell PH; Ratcliffe PJ; Maher ER Oncogene; 2001 Aug; 20(36):5067-74. PubMed ID: 11526493 [TBL] [Abstract][Full Text] [Related]
57. Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation. Turner KJ; Moore JW; Jones A; Taylor CF; Cuthbert-Heavens D; Han C; Leek RD; Gatter KC; Maxwell PH; Ratcliffe PJ; Cranston D; Harris AL Cancer Res; 2002 May; 62(10):2957-61. PubMed ID: 12019178 [TBL] [Abstract][Full Text] [Related]
58. Focus on kidney cancer. Linehan WM; Zbar B Cancer Cell; 2004 Sep; 6(3):223-8. PubMed ID: 15380513 [No Abstract] [Full Text] [Related]